Literature DB >> 12853121

Limited proteolysis of surfactant protein D causes a loss of its calcium-dependent lectin functions.

M Griese1, A Wiesener, F Lottspeich, Ch von Bredow.   

Abstract

Surfactant protein D (SP-D) is a multimeric collagenous lectin that mediates the clearance of pathogens and modulates immune cell functions via its C-terminal carbohydrate recognition domain (CRD). We hypothesized that extracellular proteolysis of SP-D may result in a loss of its functional properties. Multimeric SP-D was partially digested by human leukocyte elastase (HLE) dose- and time-dependently. Physiologic concentrations of calcium slowed, but did not protect from degradation. In solution, both native and degraded SP-D had an apparent molecular weight of 650 to >1000 kDa. Under reducing conditions, the degraded SP-D monomers run at 10 kDa less than native SP-D. Amino acid sequencing located all major cleavage sites into the CRD. Functional studies showed that degraded SP-D had lost its calcium-dependent lectin properties, i.e. neither bound to mannose nor agglutinated bacteria. These studies demonstrate that elastase results in the limited proteolysis of SP-D with loss of its CRD-dependent activities and suggest that proteases at concentrations observed in various lung diseases may impair the antimicrobial and immunomodulatory roles of SP-D.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853121     DOI: 10.1016/s0925-4439(03)00063-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Increased surfactant protein D fails to improve bacterial clearance and inflammation in serpinB1-/- mice.

Authors:  J Michael Stolley; Dapeng Gong; Kalamo Farley; Picheng Zhao; Jessica Cooley; Erika C Crouch; Charaf Benarafa; Eileen Remold-O'Donnell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-09-28       Impact factor: 6.914

2.  Measuring protein structural changes on a proteome-wide scale using limited proteolysis-coupled mass spectrometry.

Authors:  Simone Schopper; Abdullah Kahraman; Pascal Leuenberger; Yuehan Feng; Ilaria Piazza; Oliver Müller; Paul J Boersema; Paola Picotti
Journal:  Nat Protoc       Date:  2017-10-26       Impact factor: 13.491

Review 3.  S-nitrosylation of surfactant protein D as a modulator of pulmonary inflammation.

Authors:  Elena N Atochina-Vasserman
Journal:  Biochim Biophys Acta       Date:  2011-12-13

4.  Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo.

Authors:  Sadis Matalon; Kedar Shrestha; Marion Kirk; Stephanie Waldheuser; Barbara McDonald; Kelly Smith; Zhiqian Gao; Abderrazzak Belaaouaj; Erika C Crouch
Journal:  FASEB J       Date:  2009-01-06       Impact factor: 5.191

5.  Sequential analysis of surfactant, lung function and inflammation in cystic fibrosis patients.

Authors:  Matthias Griese; Robert Essl; Reinhold Schmidt; Manfred Ballmann; Karl Paul; Ernst Rietschel; Felix Ratjen
Journal:  Respir Res       Date:  2005-11-07

Review 6.  SP-A and SP-D: Dual Functioning Immune Molecules With Antiviral and Immunomodulatory Properties.

Authors:  Alastair Watson; Jens Madsen; Howard William Clark
Journal:  Front Immunol       Date:  2021-01-19       Impact factor: 7.561

7.  NET balancing: a problem in inflammatory lung diseases.

Authors:  Olivia Z Cheng; Nades Palaniyar
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

8.  MMP-9 cleaves SP-D and abrogates its innate immune functions in vitro.

Authors:  Preston E Bratcher; Nathaniel M Weathington; Heidi J Nick; Patricia L Jackson; Robert J Snelgrove; Amit Gaggar
Journal:  PLoS One       Date:  2012-07-30       Impact factor: 3.240

Review 9.  Surfactant Protein D in Respiratory and Non-Respiratory Diseases.

Authors:  Grith L Sorensen
Journal:  Front Med (Lausanne)       Date:  2018-02-08

Review 10.  Surfactant Protein D Recognizes Multiple Fungal Ligands: A Key Step to Initiate and Intensify the Anti-fungal Host Defense.

Authors:  Taruna Madan; Uday Kishore
Journal:  Front Cell Infect Microbiol       Date:  2020-05-29       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.